You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Progressing

Showing 1 - 25 of 1,686
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myopia Trial in Hung Hom (DIMS spectacle lens)

Not yet recruiting
  • Myopia
  • DIMS spectacle lens
  • Hung Hom, Hong Kong
    School of Optometry, The Hong Kong Polytechnic University
May 24, 2023

Myopia Trial in Hung Hom (Variant of Defocus Incorporated Spectacle lens (DG2))

Not yet recruiting
  • Myopia
  • Variant of Defocus Incorporated Spectacle lens (DG2)
  • Hung Hom, Hong Kong
    School of Optometry, The Hong Kong Polytechnic University
May 24, 2023

Breast Cancer Stage IV Trial in Vienna (Datopotamab deruxtecan)

Recruiting
  • Breast Cancer Stage IV
  • Datopotamab deruxtecan
  • Vienna, Austria
    AKH Universitaetsklinikum Vienna, Department f. Internal medicin
May 19, 2023

COVID-19 Respiratory Infection Trial (Azvudine, Placebo)

Not yet recruiting
  • COVID-19 Respiratory Infection
  • (no location specified)
Jan 17, 2023

Brain Metastases Trial in Houston (Niraparib, Dostarlimab)

Not yet recruiting
  • Brain Metastases
  • Houston, Texas
    M D Anderson Cancer Center
Jan 17, 2023

Small Cell Lung Carcinoma Trial in Milano (Cyclic, 5-day calorie restriction, Atezolizumab)

Not yet recruiting
  • Small Cell Lung Carcinoma
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Jan 19, 2023

Coronary Arteriosclerosis Trial in Paris (injection of 68Ga-DOTATATE)

Terminated
  • Coronary Arteriosclerosis
  • injection of 68Ga-DOTATATE
  • Paris, France
    service de médecine nucléaire-Hôpital Bichat
Jun 29, 2022

Sperm Motility and IUI Live Birth Rate

Not yet recruiting
  • Infertility
  • Assessment the pre-washed sperm motility before IUI
  • (no location specified)
Nov 3, 2023

The Value of Orencia in Rapidly Progressing Rheumatoid Arthritis

Completed
  • Rheumatoid Arthritis
  • Non-interventional
  • Beverly Hills, California
  • +6 more
Jul 1, 2022

Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Helsinki (TILT-123, Avelumab)

Recruiting
  • Melanoma
  • Head and Neck Squamous Cell Carcinoma
  • Helsinki, Finland
    Docrates Cancer Center
Jul 12, 2022

Desmoid Tumor Trial in France (Cryoablation, Chemotherapy drug)

Not yet recruiting
  • Desmoid Tumor
  • Cryoablation
  • Chemotherapy drug
  • Bordeaux, France
  • +12 more
Oct 6, 2023

Breast Cancer, Metastatic Breast Cancer Trial (Trastuzumab-Deruxtecan (T-DXd))

Not yet recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • Trastuzumab-Deruxtecan (T-DXd)
  • (no location specified)
Sep 20, 2023

Breast Cancer Metastatic Trial in Spain (Irinotecan Hydrochloride)

Recruiting
  • Breast Cancer Metastatic
  • Irinotecan Hydrochloride
  • Badalona, Spain
  • +19 more
Jan 18, 2023

Myopia Progressing, Childhood Trial in Strasbourg (Atropine 0.01%, Placebo)

Recruiting
  • Myopia Progressing
  • Childhood
  • Atropine 0.01%
  • Placebo
  • Strasbourg, France
    CHU de Strasbourg
Aug 5, 2021

Waldenstrom Macroglobulinemia, DASATINIB Trial in Boston (Dasatinib)

Recruiting
  • Waldenstrom Macroglobulinemia
  • DASATINIB
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 22, 2022

Metastatic or Locally Advanced NSCLC Trial in Ramat Gan (Durvalumab, Tremelimumab, Low dose irradiation)

Recruiting
  • Metastatic or Locally Advanced NSCLC
  • Ramat Gan, Israel
    Sheba Medical Centre
Jan 9, 2022

Breast Cancer Stage IV Trial in Vienna (Trastuzumab deruxtecan)

Active, not recruiting
  • Breast Cancer Stage IV
  • Trastuzumab deruxtecan
  • Vienna, Austria
    AKH Universitaetsklinikum Vienna, Department f. Internal medicin
Jul 26, 2022

Prostatic Tumors Trial in New York, Myrtle Beach, Houston (ORIC-101, enzalutamide 40 MG oral capsule [Xtandi])

Active, not recruiting
  • Prostatic Neoplasms
  • ORIC-101
  • enzalutamide 40 MG oral capsule [Xtandi]
  • New York, New York
  • +2 more
Sep 22, 2022

Advanced or Unresectable Melanoma Progressing After PD1 Blockade Trial in Norway, United States (ONCOS-102, Cyclophosphamide,

Completed
Has Results
  • Advanced or Unresectable Melanoma Progressing After PD1 Blockade
  • ONCOS-102
  • +2 more
  • Baltimore, Maryland
  • +3 more
Oct 11, 2021

Metastatic Breast Cancer Trial in East Melbourne (BYl719)

Completed
  • Metastatic Breast Cancer
  • East Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Aug 11, 2022

Dalpiciclib Combined With Third-generation EGFR-TKI in EGFR

Not yet recruiting
  • Non-small Cell Lung Cancer Confirmed by Histopathology or Cytology
  • +6 more
    • (no location specified)
    Aug 9, 2022

    Open Angle Glaucoma Trial in Albury, Melbourne (ONL1204 Ophthalmic solution (Dose A), ONL1204 Ophthalmic solution (Dose B), Sham

    Not yet recruiting
    • Open Angle Glaucoma
    • ONL1204 Ophthalmic solution (Dose A)
    • +2 more
    • Albury, New South Wales, Australia
    • +1 more
    Dec 6, 2021

    Metastatic NSCLC (NSCLC) Trial in Sacramento (Avelumab, Stereotactic ablative radiotherapy (SAR))

    Completed
    • Metastatic Non-small Cell Lung Cancer (NSCLC)
    • Avelumab
    • Stereotactic ablative radiotherapy (SAR)
    • Sacramento, California
      UC Davis
    Oct 19, 2021

    Stage 3 Age Related Macular Degeneration (AREDS Classification) Trial in Lyon (MAIA™ (Centervue, Padova, Italy; distributed in

    Completed
    • Stage 3 Age Related Macular Degeneration (AREDS Classification)
    • MAIA™ (Centervue, Padova, Italy; distributed in France by EDC Lamy, Carvin, France)
    • Lyon, France
      Hospice Civils de Lyon
    Sep 21, 2021

    Patients With Stage IV or Recurrent Adenocarcinoma of the Lung Trial (Abraxane, Gemcitabine)

    Completed
    Has Results
    • Patients With Stage IV or Recurrent Adenocarcinoma of the Lung
    • (no location specified)
    Sep 28, 2021